NEETPGAI
BlogPricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Subjects
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Help Center

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Medicine/Jaundice — Approach and Differential
    Jaundice — Approach and Differential
    medium
    stethoscope Medicine

    A 35-year-old woman presents with jaundice, fever, and right upper quadrant pain for 3 days. Serum bilirubin is 6.8 mg/dL (conjugated 5.2 mg/dL), ALT 680 U/L, AST 520 U/L, ALP 145 U/L. Abdominal ultrasound shows dilated intrahepatic and extrahepatic bile ducts with a 12 mm stone in the common bile duct. Which investigation is most appropriate to confirm the diagnosis and plan definitive management?

    A. Computed tomography abdomen
    B. Hepatobiliary scintigraphy (HIDA scan)
    C. Endoscopic ultrasound (EUS)
    D. Magnetic resonance cholangiopancreatography (MRCP)

    Explanation

    ## Investigation of Choice for Suspected Choledocholithiasis ### Clinical Context The patient presents with: - Acute cholangitis triad: fever, jaundice, RUQ pain - Markedly elevated transaminases (ALT 680, AST 520) — hepatocellular pattern - Conjugated hyperbilirubinemia - **Ultrasound findings: dilated ducts + CBD stone 12 mm** This is **acute obstructive jaundice** due to **choledocholithiasis** (CBD stone). ### Why MRCP? **Key Point:** MRCP is the **non-invasive imaging gold standard** for confirming choledocholithiasis and assessing the biliary tree anatomy because it: 1. Has **high sensitivity (90–95%) and specificity (95–98%)** for CBD stones 2. Visualizes the entire biliary tree and pancreatic duct in detail 3. Detects stone size, number, and location precisely 4. Is **non-invasive** (no endoscopy, no contrast injection into ducts) 5. Identifies complications: strictures, dilated ducts, pancreatitis 6. **Guides decision-making**: if stone confirmed, proceed to ERCP for therapeutic removal **High-Yield:** MRCP is the **bridge investigation** between ultrasound (which shows obstruction) and ERCP (which is therapeutic). It confirms diagnosis and anatomy before intervention. ### Diagnostic Algorithm: Obstructive Jaundice with Suspected CBD Stone ```mermaid flowchart TD A[Jaundice + RUQ pain + fever]:::outcome --> B[Ultrasound]:::action B --> C{Dilated ducts + stone?}:::decision C -->|Yes| D[MRCP for confirmation & anatomy]:::action C -->|No| E[MRCP to rule out stone]:::action D --> F{Stone confirmed?}:::decision E --> G{Stone found?}:::decision F -->|Yes| H[ERCP + sphincterotomy + extraction]:::action G -->|No| I[Consider other causes: stricture, malignancy, pancreatitis]:::outcome H --> J[Symptom resolution]:::outcome ``` **Clinical Pearl:** In acute cholangitis (fever + jaundice + obstruction), ERCP is **both diagnostic and therapeutic**. However, MRCP is preferred first to confirm anatomy and stone presence, especially if ERCP is high-risk (altered anatomy, coagulopathy). In this case, MRCP confirms the diagnosis before proceeding to ERCP. ### Comparison of Investigations for CBD Stone | Investigation | Sensitivity | Specificity | Invasive? | Therapeutic? | Best Use | |---|---|---|---|---|---| | **Ultrasound** | 50–70% | 95% | No | No | Initial screening; detects dilation | | **MRCP** | 90–95% | 95–98% | No | No | **Gold standard for confirmation** | | **EUS** | 95–98% | 98–99% | Yes (endoscopy) | No | When MRCP unavailable; high sensitivity | | **CT** | 70–85% | 90% | No | No | Staging, complications, alternative diagnosis | | **HIDA scan** | 80–90% | 85% | No | No | Assesses biliary excretion; not for stone detection | | **ERCP** | 90–95% | 95% | Yes | **Yes** | **Therapeutic gold standard** | **Mnemonic:** **MRCP before ERCP** — Confirm (MRCP) before you Treat (ERCP). ### Why Not the Other Options? **EUS (Endoscopic Ultrasound):** - Has slightly higher sensitivity (95–98%) than MRCP for small stones - Is **invasive** (requires endoscopy) - Does **not** visualize the entire biliary tree (limited field) - Operator-dependent - Reserved for cases where MRCP is equivocal or unavailable **CT Abdomen:** - Sensitivity only 70–85% for CBD stones - Less detailed than MRCP for biliary anatomy - Useful for staging complications (pancreatitis, perforation) but not diagnostic confirmation **HIDA Scan (Hepatobiliary Scintigraphy):** - Assesses **biliary excretion and cystic duct patency** (useful for acute cholecystitis) - Does **not detect stones** reliably - Poor spatial resolution - Not indicated for suspected choledocholithiasis **Tip:** Remember the **investigation hierarchy for obstructive jaundice**: 1. **Ultrasound** → detects dilation, rules in/out obstruction 2. **MRCP** → confirms diagnosis, assesses anatomy 3. **ERCP** → therapeutic intervention (stone removal, stent placement) **Warning:** Do not confuse MRCP (diagnostic imaging) with ERCP (therapeutic endoscopy). MRCP is the **investigation of choice** for confirmation; ERCP is the **treatment of choice** for stone removal. ![Jaundice — Approach and Differential diagram](https://mmcphlazjonnzmdysowq.supabase.co/storage/v1/object/public/blog-images/explanation/13265.webp)

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Medicine Questions